ESO Masterclass in Cancer Patient Advocacy
July 08, 2016|
By Tore Aasbu|
INCA has had the pleasure of participating in the 2nd Masterclass in Cancer Patient Advocacy: Working Towards Stronger and More Effective Advocacy in Europe, taking place on 24-26 June in Milan, Italy.
INCA shares best practice
Evidence-based activism at the 2nd Masterclass in Cancer Patient Advocacy held by European School of Oncology (ESO)
Targeted at highly experienced cancer patient advocacy leaders, the Masterclass aims to enhance their understanding of key cancer policy issues and develop their advocacy skills. Most of the cancer patient organisations active at a European or international level have sent delegates to the Masterclass, with 43 cancer patient advocates from 18 umbrella patient organisations in attendance. INCA was represented by Tore Aasbu, INCA Board Member and Teodora Kolarova, INCA Executive Director.
INCA shares best practice in evidence-based activism
In addition to partaking in the intensive and insightful sessions, and the valuable networking opportunities, INCA also had the chance to share its best-practice experience in evidence-based activism during the Generating patient evidence: Learning from the experience of cancer patient advocacy groups module. Teodora showcased the success story of the Global NET Patient Survey – a collaborative effort between INCA and Novartis – in terms of strengthening the patient voice and engaging various key stakeholders to make an impact.